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Abstract 
Background: Serotonin (5‑HT) improves insulin sensitivity and glucose metabolism, however, the underlying 
molecular mechanism has remained elusive. Previous studies suggest that 5‑HT can activate intracellular small 
GTPases directly by covalent binding, a process termed serotonylation. Activated small GTPases have been associated 
with increased GLUT4 translocation to the cell membrane. Therefore, we investigated whether serotonylation of small 
GTPases may be involved in improving Insulin sensitivity and glucose metabolism.
Methods: Using fully differentiated L6 rat skeletal muscle cells, we studied the effect of 5‑HT in the absence or pres‑
ence of insulin on glycogen synthesis, glucose uptake and GLUT4 translocation. To prove our L6 model we addition‑
ally performed preliminary experiments in C2C12 murine skeletal muscle cells.
Results: Incubation with 5‑HT led to an increase in deoxyglucose uptake in a concentration‑dependent fashion. 
Accordingly, GLUT4 translocation to the cell membrane and glycogen content were increased. These effects of 5‑HT 
on Glucose metabolism could be augmented by co‑incubation with insulin and blunted by co incubation of 5‑HT 
with monodansylcadaverine, an inhibitor of protein serotonylation. In accordance with this observation, incubation 
with 5‑HT resulted in serotonylation of a protein with a molecular weight of approximately 25 kDa. We identified this 
protein as the small GTPase Rab4, the activity of which has been shown to be stimulated by both insulin signalling 
and serotonylation.
Conclusion: Our data suggest that 5‑HT elicits its beneficial effects on Glucose metabolism through serotonylation 
of Rab4, which likely represents the converging point between the insulin and the 5‑HT signalling cascades.
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Background
Serotonin (5-hydroxytryptamine, 5-HT), the biogenic 
amine of the amino acid tryptophan, affects a broad 
range of behavioural, cognitive and physiological func-
tions. 5-HT action is mediated by the binding of 5-HT 
to 5-HT-receptors that are divided into seven distinct 
classes (5-HT1 to 5-HT7) based on their structural and 
functional characteristics [1]. Medication that affects 
5-HT metabolism is known to alter glucose homeostasis 
including antidepressants such as some selective 5-HT 
reuptake inhibitors (SSRIs), which increase 5-HT lev-
els in the synaptic cleft, improve insulin sensitivity and 
glucose metabolism [2]. However, some second genera-
tion antipsychotics (SGAs) that antagonize the 5-HT2A-
receptor (5-HT2AR) and inhibit the phosphoinositol-3 
kinase (PI3  K)-dependent insulin signalling pathway [3] 
cause weight gain and insulin resistance [4], suggesting a 
link between serotonin and the PI3 K pathway. Support-
ing these findings, more recent studies have shown that 
some 5-HT2AR gene polymorphisms are associated with 
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homeostasis. Accordingly, patients harbouring these 
polymorphisms are more likely to develop diabetes under 
SGA-therapy [5, 6].
The underlying molecular mechanisms causing the 
improvement in insulin sensitivity and glucose metabo-
lism by 5-HT and the connection between the serotonin 
and the PI3 K pathways are not fully understood.
Recently, several studies showed a novel mechanism of 
protein activation by covalent binding of 5-HT to a num-
ber of intracellular proteins after entering the cell through 
the 5-HT-reuptake transporter (SERT). This process 
is catalysed by transglutaminases and also involves the 
extracellular activation of 5-HT2AR to increase intracel-
lular Ca2+ -levels, which are needed for the activation of 
these Ca2+  -dependent transglutaminases. One group of 
proteins activated by serotonylation are intracellular small 
GTPases. Paulman et al. showed in 2009 that serotonyla-
tion of small Rab-GTPases activates these proteins in 
pancreatic beta cells, promoting glucose-mediated insulin 
secretion [7]. Additionally, this group showed that trypto-
phan hydroxylase 1 knockout mice, which lack the enzyme 
needed to produce 5-HT, develop diabetes [8]. In support 
of these data, other research groups found that transglu-
taminase 2 knockout mice also become diabetic [9].
Activated small GTPases have been shown to regulate 
many steps in intracellular trafficking, such as vesicle for-
mation, movement and membrane fusion [10]. Insulin-
responsive tissues, such as skeletal muscle and adipose 
tissue, express several Rab and Rho isozymes. These acti-
vated small GTPases have been associated with GLUT4 
translocation to the cell membrane, a process linked to 
the PI3 K-dependent insulin signalling pathway [11].
The aim of this study was to investigate whether the 
activation of Rab- and/or Rho-GTPases by serotonyla-
tion could represent the mechanism by which 5-HT 
increases GLUT4 translocation to the cell membrane, 
thus, increasing glucose transport and restoring glu-
cose homeostasis. Here, we provide evidence that sero-
tonylation of the small GTPase Rab4 represents the link 




Amyloglucosidase and all inorganic reagents (mHT, 
5-HT, MDC, pargyline) were from Sigma (St. Louis, MO, 
USA). The ECL-kit was from Amersham Biosciences 
(Buckinghamshire, UK). The [14C]-molecular weight 
marker, 2-deoxy-[1-3H]-glucose and 5-[1.2–3H(N)]-
5-HT were from Perkin-Elmer (Boston, MA, USA). 
The 4–15% linear-gradient mini gels were from Bio-
Rad (Hercules, CA, USA). Anti-Rab4 and the Rab- and 
Rho-GTPases sampler kits were from Cell Signaling 
Technology (Beverly, MA, USA). Anti-SERT, anti-Rho, 
anti-GLUT4 antibodies and the anti-pan-cadherin anti-
body were from Abcam (Cambridge, UK). The 5-HT-
antibody was from AbDSerotec (Duesseldorf, Germany). 
The L6 rat skeletal muscle cell line, as well as the C2C12 
cell line, the CaCo2 cell line and the PMC cell line were 
obtained from ATCC (Manassas, VA, USA). α-MEM, 
Eagle’s MEM and RPMI 1640 were purchased from 
Sigma (St. Louis, MO, USA), FCS from Biochrom AG 
(Berlin, Germany), BCS and fatty acid/insulin-free BSA 
from Sigma (St. Louis, MO, USA).
Cell culture
L6 and C2C12 skeletal muscle cells—were cultured at 
37  °C with 5% CO2 and used up to the ninth passage 
for the L6 cells. C2C12 were used following the second 
passage. Cells were grown to confluency in α-MEM con-
taining 10% FCS and then switched to the same media 
containing 2% FCS for differentiation. Experiments were 
performed with fully differentiated myotubes 12–14 days 
post-confluency for the L6 and on the 6th day post-con-
fluency for the C2C12 cells.
PBMC cells—were cultured at 37  °C with 5% CO2. 
Cells were grown in RPMI 1640 containing 10% BCS.
CaCo2 cells—were cultured at 37  °C with 5% CO2. 
Cells were grown in Eagle’s MEM containing 10% FCS.
Incubation experiments—One day prior to the experi-
ments, the medium was replaced with starvation medium 
containing serum-free α-MEM with 0.25% insulin-free 
BSA. The next morning, cells were incubated with 5-HT 
(in the concentration 0.01; 0.1; 1; 10 and/or 100  µM as 
indicated in the respective figure legends), mHT (in the 
concentration 0.01; 0.1; 1; 10 and/or 100 µM as indicated 
in the respective figure legends), 25  µM MDC, 1  µM 
pargyline in the absence or presence of 100  nM insulin 
for the lengths of time indicated in the respective figure 
legends.
Then, cells were lysed and analysed for glucose uptake, 
glycogen content, GLUT4 translocation and protein 
content.
Deoxyglucose uptake and calculation of the apparent 
Vmax and Km
After starvation, cells were incubated in HBS for 1 h in 
the absence and presence of methyl-5-HT (mHT), 5-HT, 
monodansylcadaverine (MDC), pargyline and insulin 
at 37  °C. Then, 2-deoxyglucose uptake was measured as 
previously described by our group [12]. Vmax and Km 
values were calculated using non-linear least square fit-
ting (MatLab, version 6.1, The MathWorks, Natick, MA, 
USA).
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Glycogen content
After starvation, cells were incubated with the respec-
tive reagents in the absence or presence of insulin for 1 h. 
Glycogen content was then analysed by the method of 
[13] with minor modifications as previously described by 
our group [14].
Western blot analysis—Following starvation overnight, 
L6 cells and C2C12 cells were incubated for 1  h in the 
absence and presence of 5-HT, MDC, pargyline and insu-
lin as indicated in the respective figure legends. All sub-
sequent steps for Western blot analysis were performed 
as previously described [14]. As a loading control, an 
antibody against β-actin was used.
Membrane protein isolation for the analysis of GLUT4 
translocation - This experiment was performed in the 
absence or presence of 5-HT, MDC, pargyline and insu-
lin following overnight starvation. Cells were washed 
with PBS and collected in buffer 1 (5 mM Tris–HCL pH 
7.4, 2 mM EDTA and protease inhibitors). Lysis was per-
formed by sonification, and lysates were centrifuged for 
15 min at 500×g. The supernatant of this centrifugation 
step was again centrifuged at 45.000×g for 15  min. The 
resulting pellet was washed in buffer 1 and resuspended 
in buffer 2 (75  mM Tris–HCl pH 7.4, 12.5  mM MgCl2, 
5  mM EDTA). All subsequent steps for Western blot 
analysis were performed as previously described [14]. 
To control for loading, an antibody against pan-cadherin 
was used.
5‑HT uptake assay
Uptake measurements were performed with overnight 
starved cells at increasing 5-HT concentrations as indi-
cated in the respective figure legend. Krebs–Ringer-
HEPES (KRH)-buffer was used as an incubation media. 
As a reaction buffer, KRH-buffer containing 3[H]-5-HT 
was used. The cells were immediately washed with KRH-
buffer and incubated with the reaction buffer at room 
temperature for 1, 12, 60 and 360  s at the concentra-
tions indicated [15]. Cells were then solubilized in 0.05 M 
NaOH, and samples were analysed in a scintillation 
counter. Vmax and Km values were calculated using non-
linear least square fitting in a Michaelis–Menten model 
(MatLab, version 6.1, The MathWorks, Natick, MA, 
USA).
AnnexinV-Apoptosis Assay—Apoptosis/necrosis in L6 
cells was evaluated by Annexin V/PI (propidium iodide) 
double staining. We could not detect any necrosis/apop-
tosis by AnnexinV/PI-staining with 5-HT, mHT, MDC 
and pargyline incubations.
Data analysis
ANOVA for repeated measurements was performed for 
the factors insulin and mHT, 5-HT, MDC and pargyline. 
When univariate analysis revealed significant differ-
ences, post hoc comparisons were made using Bonfer-
roni’s least significant difference method. Otherwise, 
univariate results were stated. All values were expressed 
as mean ± S.D., and statistical significance was accepted 
as P < 0.05.
Results
Expression of SERT and cellular uptake of 5‑HT
First, we studied the expression of the 5-HT re-uptake 
transporter SERT and the cellular uptake of 5-HT. West-
ern blot analysis revealed that SERT is expressed on the 
cell membrane of L6 and C2C12 skeletal muscle cells 
(Fig.  1). Expression of SERT on L6 cells was compared 
with CaCo2 cells (human colon carcinoma cell line) and 
PBMC cells (monocyte cell line) two cell lines for which 
SERT-expression has been previously described [16, 17] 
(Fig. 1a).
Moreover, 5-HT uptake into L6 skeletal muscle cells 
occurred in a time- and concentration-dependent fash-
ion (Fig. 1b).
Fig. 1 a SERT‑expression in L6 and C2C12 skeletal muscle cells. Western 
blot analysis of total cell lysates using a SERT‑specific antibody. 
Expression of SERT was compared between CaCo2 cells (human 
colon carcinoma cell line) and PBMC cells (monocyte cell line) two 
cell lines for which SERT‑expression has been previously described 
[16, 17], and L6 cells (N = 6) and C2C12 cells respectively (N = 2). b 
Concentration‑ and time‑dependent uptake of 5‑HT into L6 cells using 
radioactive 5‑HT. L6 cells were incubated for increasing incubation 
times (1, 12, 60 and 360 s) and increasing [3H]‑labelled 5‑HT concen‑
trations (0.01; 0.1; 1; 10 and 100 µM) and analysed for 5‑HT uptake. 
Bars represent the mean ± S.D. for three experiments performed in 
triplicates. Significant differences are indicated as *P < 0.05 **P < 0.01 
***P < 0.001 for comparisons to the condition at 1 s incubation time 
and at the same 5‑HT concentration, and +P < 0.05 +++P < 0.001 
for comparisons to condition at 1 s incubation time and at the 5‑HT 
concentration of 0.01 µM
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5‑HT and mHT increase glucose uptake and glycogen 
content in a concentration‑dependent fashion
In these experiments, we used L6 cells to study the effect 
of both 5-HT and methyl-5-HT (mHT), a more specific 
ligand for the 5-HT2AR than 5-HT, on glucose uptake 
(Fig.  2a, b) and glycogen content (Fig.  2 c, d); 5-HT 
induced a significant increase in glucose uptake, how-
ever, only with 5-HT at a concentration of 10 µM in the 
absence of insulin (Fig. 2a). Glycogen content was signifi-
cantly increased at a concentration of 10 µM 5-HT both 
in the absence and presence of insulin (Fig.  2c). With 
mHT, significance was reached at 1  µM but only in the 
presence of insulin (Fig. 2d).
Interestingly, the effects of 5-HT and mHT on glucose 
uptake and glycogen content were augmented in the 
presence of insulin. To characterize the kinetics of 5-HT-
induced glucose uptake, a Michaelis–Menten kinetic 
model using non-linear least square fitting was used. 
With this model, we observed additive mechanisms for 
insulin and 5-HT action on glucose uptake.
As shown in Fig.  3, insulin elicited the expected 
increase in GLUT4 translocation. In the absence of insu-
lin, GLUT4 translocation was augmented with 5-HT 
incubation, indicating that increased GLUT4 transloca-
tion represents the basis of the observed positive effects 
of 5-HT on glucose metabolism.
As 5-HT had a more pronounced and consistent 
effect on glucose metabolism than mHT, only 5-HT at 
a concentration of 10 µM was used for all the following 
experiments.
Effect of pargyline and monodansylcadaverine on 5‑HT 
induced increases in glucose uptake, GLUT4 translocation 
and glycogen content
To determine whether 5-HT itself or its metabolites were 
responsible for the positive effects on glucose metabolism 
in L6 cells, the degradation of 5-HT was blocked with 
pargyline, a substance that inhibits the enzymatic activ-
ity of MAO. As shown in Fig. 4, pargyline did not dimin-
ish the 5-HT-induced increase of GLUT4-translocation 
Fig. 2 a, b Analysis of glucose uptake with increasing concentrations of 5‑HT (a) or mHT (b). L6 cells were incubated with increasing concentrations 
of either 5‑HT or mHT in the presence (solid bar) or absence (empty bar) of 100 nM insulin for 1 h. Significant differences are indicated as *P < 0.05 
for comparison to the condition at 0 nM of 5‑HT in the absence of insulin. (N ≥ 3 in triplicate). c, d Analysis of glycogen content with increasing 
concentrations of 5‑HT (c) or mHT (d). L6 cells were incubated with increasing concentrations of either 5‑HT or mHT in the presence (solid bar) or 
absence (empty bar) of 100 nM insulin for 3 h. Significant differences are indicated as **P < 0.01 for comparison to the condition at 0 nM of 5‑HT in 
the absence of insulin and ++P < 0.01 or +++P < 0.001 for comparison to the condition at 0 nM of 5‑HT or mHT in the presence of insulin (N ≥ 3 in 
triplicate)
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(Fig. 4a, b), glucose uptake (Fig. 4c) or glycogen content 
(Fig. 4d).
To determine whether the effects of 5-HT were medi-
ated by serotonylation of intracellular proteins, we used 
L6 cells and co-incubated 5-HT with monodansylcadav-
erine (MDC), a drug known to inhibit protein-seroto-
nylation by blocking transglutaminases. MDC incubation 
at a concentration of 25  µM blunted the 5-HT-induced 
increase of GLUT4 translocation (Fig.  4a, b), glucose 
uptake (Fig.  4c) and glycogen content (Fig.  4d), both in 
the absence and presence of insulin.
5‑HT induces serotonylation of several intracellular 
proteins
To study whether 5-HT affects the serotonylation of intra-
cellular proteins, we performed Western blot analyses with 
a 5-HT-specific antibody both in the absence and presence 
of 5-HT using L6 cells. As shown in Fig. 5a, direct blotting 
of cell lysates revealed several bands at various molecular 
weights. However, the signal of only three of these bands 
at molecular weights ranging from 5 to 25 kDa could be 
blunted by MDC incubation suggesting serotonylation of 
the corresponding proteins. L6 cells incubated with 3[H]-
labelled 5-HT followed by SDS gel analyses of the cell 
lysates revealed a single band at a molecular weight slightly 
above 20 kDa (Fig. 5b). Incubation in the presence of non-
labelled 5-HT abrogated this signal.
5‑HT induces serotonylation of Rab4
To identify the band at a molecular weight slightly above 
20  kDa, we performed immunoprecipitations with anti-
phospho-serine, anti-phospho-threonine and anti-phos-
pho-tyrosine antibodies, and immunoblotted with an 
antibody against 5-HT using L6 cells. These experiments 
showed no bands. Subsequently, we incubated L6 cells 
with 3[H]-labelled 5-HT and performed immunoprecipi-
tations with anti-phospho-serine, anti-phospho-threo-
nine and anti-phospho-tyrosine antibodies. Again, no 
bands were detectable (data not shown).
Next, we performed immunoprecipitations using L6 
cells with antibodies against Rab4 and Rho proteins, 
both known to have molecular weights of approximately 
25 kDa and to be serotonylated. Western blotting of the 
precipitates using a 5-HT-specific antibody was per-
formed in the absence and presence of 5-HT. These 
experiments revealed that 5-HT increases the intensity of 
the band upon precipitation with the Rab4 antibody, and 
the strength of this signal could be reduced by co-incu-
bation with MDC (Fig.  5c). To prove our L6 model we 
repeated the immunoprecipitation experiment with Rab4 
using C2C12 murine cells. These experiments found 
again that 5-HT increases the intensity of the band upon 
precipitation with the Rab4 antibody, and the strength of 
this signal could be reduced by co-incubation with MDC 
(Fig.  5e). In contrast, 5-HT incubation yielded no dif-
ferences in the signal strength of the bands precipitated 
with the Rho antibody (Fig. 5d).
To confirm that the band at approximately 25 kDa cor-
responds to Rab4, cells were incubated with 3[H]-labelled 
5-HT followed by immunoprecipitation of the cell lysate 
with an antibody against Rab4. As shown in Fig. 6, a sig-
nal could be detected at the expected molecular weight 
of Rab4.
Discussion
As mentioned in the introduction section, accumulat-
ing evidence indicates that 5-HT exerts a positive effect 
on whole body glucose homeostasis [2, 4]. However, the 
underlying molecular mechanisms are not fully under-
stood. Here, we present evidence that transglutaminase-
induced serotonylation of Rab4 leading to an activation 
of this protein represents a mechanism by which 5-HT 
improves glucose homeostasis in skeletal muscle cells 
(Fig. 7).
After showing that SERT is expressed on the cell mem-
brane of our models L6 rat skeletal muscle cells and addi-
tionally in C2C12 murine skeletal muscle cells (Fig.  1a) 
and that L6 cells are able to take up 5-HT in a dose- and 
time-dependent manner (Fig. 1b), we demonstrated that 
5-HT is able to increase glucose uptake (Fig. 2a), glyco-
gen content (Fig. 2c) and GLUT4 translocation to the cell 
Fig. 3 5‑HT increases GLUT‑4 translocation. L6 cells were incubated 
with 10 µM 5‑HT or mHT in the absence or presence of 100 nM insu‑
lin for 1 h. After cell lysis, the lysates were used for membrane protein 
isolation followed by immunoblotting (IB) with an antibody to GLUT4. 
Detection of pan‑cadherin (p‑Cad) was used as a loading control. 
Significant differences are indicated as **P < 0.01. (N = 4 in duplicate)
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membrane (Fig. 3) in the absence of insulin. These effects 
of 5-HT on glucose uptake (Fig.  2b), glycogen content 
(Fig.  2d) and GLUT 4 translocation (Fig.  3) were aug-
mented in the presence of insulin.
Several studies have shown that small GTPases can be 
activated by serotonylation [7, 8, 18]. Rab and Rho espe-
cially seem to be involved in intracellular insulin action 
and affect insulin-mediated GLUT4 translocation [11]. 
Although only shown in adipocytes so far, there is evi-
dence that, of the Rab-family members, Rab4 in particu-
lar plays a key role in insulin-mediated cellular processes, 
including GLUT4 vesicle trafficking [19–21].
These independent observations, led us to hypothesize 
that serotonylation of Rab and/or Rho proteins might 
represent the mechanism underlying the 5-HT-induced 
improvements in glucose metabolism. Therefore, we inves-
tigated whether serotonylation is responsible for the 5-HT 
effects on glucose metabolism in L6 cells using MDC, 
an inhibitor of transglutaminases. MDC abolished the 
5-HT-induced effects on GLUT4 translocation (Fig.  4a, 
b), glucose uptake (Fig. 4c) and glycogen content (Fig. 4d), 
supporting our hypothesis that 5-HT-induced serotonyla-
tion of intracellular proteins plays an important role in 
these processes. In contrast, pargyline did not diminish the 
5-HT-induced increase of GLUT4 translocation (Fig.  4a, 
b), glucose uptake (Fig. 4c) and glycogen content (Fig. 4d), 
indicating that 5-HT itself, and not its metabolites, exerts 
the positive effects on glucose metabolism.
In the next step, we decided to use a 5-HT specific 
antibody to further test our hypothesis. This antibody 
detected numerous bands, however, with only three 
of these bands, ranging in size from 5 to 25  kDa, were 
down-regulated by MDC (Fig.  6a). Incubating the cells 
with 3[H]-labelled 5-HT, we could detect only one band 
Fig. 4 A and B. 5‑HT‑induced GLUT‑4 translocation is reduced by MDC. L6 cells were incubated without (a) or with (b) 100 nM insulin for 1 h. Incuba‑
tions were performed with 25 µM MDC, 1 µM pargyline (P) or without either of these substances (C), in the absence or presence of 10 µM 5‑HT. 
Cell lysates were used for membrane protein isolation followed by immunoblotting (IB) with an antibody against GLUT4 (N = 3). Detection of 
pan‑cadherin (p‑Cad) was used as a loading control. Significant differences are indicated as **P < 0.01. c 5‑HT‑induced glucose uptake is reduced by 
MDC. L6 cells were incubated without or with 100 nM insulin for 1 h. Incubations were performed with 25 µM MDC, 1 µM pargyline (P) or without 
either of these substances (C), both in the absence or presence of 10 µM 5‑HT. Significant differences are indicated as *P < 0.05, ***P < 0.001 (N = 3 
in triplicate). d 5‑HT‑induced glycogen content is reduced by MDC. L6 cells were incubated without or with 100 nM insulin for 3 h. Incubations were 
performed with 25 µM MDC, 1 µM pargyline (P) or without either of these substances (C), in the absence or presence of 10 µM 5‑HT. Significant 
differences are indicated as *P < 0.05, ***P < 0.001 (N = 3 in triplicate)
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slightly above 20  kDa (Fig.  7). Incubation with addi-
tional non-labelled 5-HT abrogated this signal, indicat-
ing that it competitively replaced the 3[H]-labelled 5-HT 
(Fig. 6b). To identify this band, we performed immuno-
precipitations with antibodies against phospho-serine-, 
phospho-threonine- and phospho-tyrosine kinase in 
radioactive and non-radioactive settings. As these experi-
ments yielded no positive results (data not shown), we 
used antibodies against Rho and Rab proteins, both 
known to be activated through serotonylation [7, 8, 18] 
and also known to play roles in GLUT4 trafficking [11, 
19–21]. Using antibodies against the Rho proteins Cdc42, 
Phospho-Rac1/cdc42, Rac1/2/3, RhoA, RhoB and RhoC 
serotonylation was not detectable. However, we detected 
serotonylation following immunoprecipitation with a 
pan-Rho-antibody. Based on our observations that the 
band corresponding to the Rho protein was not affected 
by MDC and 5-HT, we concluded that Rho-serotonyla-
tion had no major role in this process (Fig.  6d). Using 
antibodies against the Rab proteins Rab4, Rab5, Rab9 and 
Fig. 5 a Western blot analysis of total cell lysates using a 5‑HT‑specific antibody. L6 cells were incubated with 25 µM MDC, 1 µM pargyline (P) or with‑
out either of these substances (C), in the absence or presence of 10 µM 5‑HT for 1 h. After cell lysis, direct blotting was performed with a 5‑HT‑specific 
antibody (N = 3). b SDS gel analysis of total cell lysates after incubation with radioactive 5‑HT. L6 cells were incubated with [3H]‑labelled 5‑HT at 1 and 
5 µCi for 1 h, then cells were lysed, and lysates were subjected to SDS gel analysis. Experiments were performed either in the absence or presence 
of non‑labelled 5‑HT at a concentration of 10 µM (N = 4). M, radiolabelled molecular weight marker. c Analysis of Rab4 serotonylation using a 5‑HT‑
specific antibody. L6 cells were incubated in the absence or presence of 10 µM 5‑HT with or without MDC for 1 h, and lysed in lysis buffer. An aliquot 
of the lysates was subjected to SDS‑PAGE for direct blotting (DB) with an antibody against Rab4, and the remaining lysate was used for immunopre‑
cipitation (IP) with an antibody against Rab4 followed by immunoblotting (IB) with an antibody against beta‑actin (ß‑Actin) as a loading control and 
5‑HT respectively. The bar graph shows the quantification of serotonylated Rab4. Bars represent the mean ± S.D. for four independent experiments, 
with significant differences indicated as ***P < 0.001, C, Control. d Analysis of Rho serotonylation using a 5‑HT‑specific antibody. L6 cells were incubated 
in the absence or presence of 10 µM 5‑HT with or without MDC for 1 h, and cells lysed in lysis buffer. An aliquot of the lysates was subjected to 
SDS‑PAGE for direct blotting (DB) with an antibody against Rho, and the remaining lysate was used for immunoprecipitation (IP) with an antibody 
against Rho followed by immunoblotting (IB) with an antibody against beta‑actin (ß‑Actin) as a loading control and 5‑HT respectively. The bar graph 
shows the quantification of serotonylated Rho. Bars represent the mean ± S.D. for four independent experiments. C, Control. e Analysis of Rab4 
serotonylation using a 5‑HT‑specific antibody. C2C12 cells were incubated in the absence or presence of 10 µM 5‑HT with or without MDC for 1 h, and 
lysed in lysis buffer. An aliquot of the lysates was subjected to SDS‑PAGE for direct blotting (DB) with an antibody against Rab4, and the remaining 
lysate was used for immunoprecipitation (IP) with an antibody against Rab4 followed by immunoblotting (IB) with an antibody against beta‑actin 
(ß‑Actin) as a loading control and 5‑HT respectively
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Rab11 only Rab4 immunoprecipitation gave a band upon 
immunoblotting with a 5-HT specific antibody, the signal 
of which was down-regulated by MDC and up-regulated 
by 5-HT, suggesting that Rab4 is activated by transglu-
taminase-dependent serotonylation (Fig. 6c).
We cannot exclude that other serotonylated proteins 
may contribute to the positive effects of 5-HT on glucose 
metabolism because MDC inhibits serotonylation of all 
proteins. Furthermore, the involvement of other Rab- or 
Rho-isoforms in addition to those examined cannot be 
excluded. Therefore, the impact of these serotonylated 
proteins on the regulation of cellular processes needs 
to be further investigated. Also proteins involved in cell 
contraction, such as actin, were reported to be activated 
by serotonylation in smooth muscle cells [22]. Because 
actin also participates in GLUT4 exocytosis and counter-
acts Rab- and Rho-GTPases, this protein may be of par-
ticular interest and will therefore be the issue of future 
experiments.
The prevalence of the metabolic syndrome and its long 
term consequences, such as cardiovascular diseases and 
type 2 diabetes mellitus, is increased in patients with 
depression and schizophrenic disorders, and the preva-
lence of depression is nearly twice as high in patients 
with type 2 diabetes as in healthy subjects [23, 24]. Con-
sidering that type 2 diabetes is the fourth leading cause 
of death in developed countries and is the leading cause 
of blindness, end stage renal disease and lower extrem-
ity amputations, and confers a two to four times greater 
risk of heart disease and stroke, the present study is of 
relevance for a considerable part of the world’s popula-
tion [25, 26].
This study focused upon skeletal muscle cells as skeletal 
muscle is the predominant site of insulin-mediated glu-
cose uptake and skeletal muscle insulin resistance is con-
sidered to be the primary defect in type 2 diabetes [27]. 
Furthermore, L6 rat skeletal muscle cells were shown to 
express the 5-HT2AR [28] and Rab4 [29], and this cell 
line is a well-established cell culture model for studying 
GLUT4 trafficking [30]. Nevertheless, use of this cell line 
restricts the translation of our results to human physiol-
ogy. First, this cell line is derived from rats, and therefore 
species-specific differences must be considered. Second, 
these cells were stimulated by a concentration of human 
insulin 100-fold above normal postprandial insulin lev-
els in humans, although the 5-HT concentrations used 
were comparable to the 5-HT levels found in platelet-
poor human plasma [31]. Therefore, we believe that Rab4 
serotonylation contributes to the effects of serotonergic 
agents on body glucose homeostasis in humans.
Conclusion
In summary, our data reveal a molecular mechanism by 
which 5-HT improves glucose metabolism in skeletal 
muscle. Our data suggest a link between the 5-HT and 
the PI3 K insulin signalling pathway because insulin can 
also activate Rab4 via AS160 [32] (Fig. 7). Future studies 
should be designed to elucidate a possible role of sero-
tonylation of Rab4 in the development of type 2 diabetes 
and to characterize other potential protein targets for 
serotonylation as the basis for 5-HT action. Our findings 
may represent the basis for future preventive and thera-
peutic strategies to overcome antipsychotic drug-induced 
insulin resistance and diabetes.
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cell lysis, immunoprecipitation using a Rab4‑antibody followed by 
SDS‑PAGE was performed. M, radiolabelled molecular weight marker
Fig. 7 Our proposed model of 5‑HT‑induced translocation of GLUT4 vesi-
cles to the cell membrane of 5‑HT‑stimulated skeletal muscle cells (based 
on previous research performed by Paulmann et al. [7] ]: Initially, extra‑
cellular 5‑HT enters the cell via the 5‑HT re‑uptake transporter (SERT) 
while Ca2 + influx increases via activation of the 5‑HT2A‑receptor 
(5‑HT2AR) by 5‑HT binding. Among other functions, Ca2 + activates 
the transglutaminase (TG) which serotonylates a variety of intracel‑
lular proteins. In skeletal muscle cells, Rab4, which plays an important 
role in the translocation of GLUT4 to the cell membrane, becomes 
serotonylated and, thereby, activated. Consequently, glucose uptake 
into the cell increases. Activation of the insulin receptor resulting in 
inhibition of AKT‑substrate 160 (AS160) also leads to the activation of 
Rab4 proteins indirectly
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